X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (5) 5
lung cancer (5) 5
mutation (4) 4
aged (3) 3
cancer therapies (3) 3
female (3) 3
hematology, oncology and palliative medicine (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
middle aged (3) 3
studies (3) 3
adult (2) 2
aged, 80 and over (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
care and treatment (2) 2
growth-factor receptor (2) 2
intention to treat analysis (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - genetics (2) 2
lung neoplasms - therapy (2) 2
melanoma (2) 2
metastasis (2) 2
survival (2) 2
1st-line therapy (1) 1
abridged index medicus (1) 1
adolescent (1) 1
analysis (1) 1
articles (1) 1
bevacizumab - administration & dosage (1) 1
biomarkers (1) 1
cancer bronchique (1) 1
cancer patients (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
chemoradiotherapy - adverse effects (1) 1
chemoradiotherapy - methods (1) 1
chest radiotherapy (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
class i phosphatidylinositol 3-kinases (1) 1
classification (1) 1
clinical outcomes (1) 1
clinical trials (1) 1
clinical-practice (1) 1
critical care medicine (1) 1
crizotinib (1) 1
development and progression (1) 1
disease-free survival (1) 1
dk/atira/pure/subjectarea/asjc/2700/2730 (1) 1
dosage and administration (1) 1
dose fractionation (1) 1
douleur (1) 1
epidermal growth factor (1) 1
erbb receptors - genetics (1) 1
erlotinib (1) 1
erlotinib hydrochloride - administration & dosage (1) 1
esophagitis - etiology (1) 1
etoposide (1) 1
etoposide - administration & dosage (1) 1
eurtac trial (1) 1
family medical history (1) 1
follow-up studies (1) 1
formation (1) 1
france - epidemiology (1) 1
gefitinib (1) 1
gene expression profiling (1) 1
gene mutations (1) 1
gene rearrangement (1) 1
general practitioner (1) 1
genetic aspects (1) 1
guidelines (1) 1
health aspects (1) 1
ii trial (1) 1
immunotherapy (1) 1
impact (1) 1
institute (1) 1
internal medicine (1) 1
international cooperation (1) 1
irradiation (1) 1
kinases (1) 1
laboratories (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - mortality (1) 1
lung neoplasms - pathology (1) 1
medical screening (1) 1
medicine and health sciences (1) 1
medicine, general & internal (1) 1
metaanalysis (1) 1
molecular biology (1) 1
motivation (1) 1
multivariate analysis (1) 1
mutations (1) 1
médecine générale (1) 1
neoplasm staging (1) 1
neutropenia (1) 1
neutropenia - etiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 984 - 993
Summary Background BRAF mutations act as an oncogenic driver via the mitogen-activated protein kinase (MAPK) pathway in non-small cell lung cancer (NSCLC).... 
Hematology, Oncology and Palliative Medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 642 - 650
Summary Background Activating BRAFV600E (Val600Glu) mutations are found in about 1–2% of lung adenocarcinomas, which might provide an opportunity for targeted... 
Hematology, Oncology and Palliative Medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1116 - 1125
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10026, pp. 1415 - 1426
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 5, pp. 435 - 444
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.